National Cancer Institute; Notice of Closed Meetings

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
May 9, 2023
Issuing agencies

Health and Human Services DepartmentNational Institutes of Health
Full Text

<html>
<head>
<title>Federal Register, Volume 88 Issue 89 (Tuesday, May 9, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 89 (Tuesday, May 9, 2023)]
[Notices]
[Pages 29913-29914]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-09776]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Cancer Prevention and Control Clinical Trials.
    Date: June 1, 2023.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W254, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Susan Lynn Spence, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W254, Rockville, Maryland 20850, 240-620-0819, 
<a href="/cdn-cgi/l/email-protection#01727472606f2f7271646f6264416f68692f666e77"><span class="__cf_email__" data-cfemail="cebdbbbdafa0e0bdbeaba0adab8ea0a7a6e0a9a1b8">[email&#160;protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI R01/R34 Advancing Adolescent Tobacco Cessation 
Intervention Review Meeting.
    Date: June 2, 2023.
    Time: 9:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W248, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Anita T. Tandle, Ph.D., Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W248, Rockville, Maryland 20850, 240-276-5085, 
<a href="/cdn-cgi/l/email-protection#7a0e1b141e161f1b3a171b131654141312541d150c"><span class="__cf_email__" data-cfemail="66120708020a0307260b070f0a48080f0e48010910">[email&#160;protected]</span></a>.

    Name of Committee: National Cancer Institute Initial Review 
Group; Institutional Training and Education Study Section (F).
    Date: June 21, 2023.
    Time: 9:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W234, Rockville, Maryland 20850 (Telephone 
Conference Call).

[[Page 29914]]

    Contact Person: Adriana Stoica, Ph.D., Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W234, Rockville, Maryland 20850, 240-276-6368, 
<a href="/cdn-cgi/l/email-protection#eab99e8583898b8bd8aa878b8386c4848382c48d859c"><span class="__cf_email__" data-cfemail="4310372c2a20222271032e222a2f6d2d2a2b6d242c35">[email&#160;protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Advanced Development of Analysis Technologies.
    Date: June 23, 2023.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W238, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W238, Rockville, Maryland 20850, 240-276-6371, 
<a href="/cdn-cgi/l/email-protection#c4a0a1a7a8b1a1ae84a9a5ada8eaaaadaceaa3abb2"><span class="__cf_email__" data-cfemail="fb9f9e98978e9e91bb969a9297d5959293d59c948d">[email&#160;protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-9: NCI Clinical and Translational Cancer Research.
    Date: June 27, 2023.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W606, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Bruce Daniel Hissong, Ph.D., Scientific Review 
Officer, Resource and Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W606, Rockville, Maryland 20850, 240-276-7752, 
<a href="/cdn-cgi/l/email-protection#eb89999e888ec58382989884858cab858283c58c849d"><span class="__cf_email__" data-cfemail="0e6c7c7b6d6b2066677d7d6160694e60676620696178">[email&#160;protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Research Project-Cooperative Agreements (U01).
    Date: June 28, 2023.
    Time: 12:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W244, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Amr M. Ghaleb, Ph.D., Scientific Review Officer, 
Research Program Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W244, Rockville, Maryland 20850, 240-276-6611, <a href="/cdn-cgi/l/email-protection#640509164a030c05080106240a0d0c4a030b12"><span class="__cf_email__" data-cfemail="ef8e829dc188878e838a8daf818687c1888099">[email&#160;protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Molecular and Cellular Analysis Technologies.
    Date: July 6-7, 2023.
    Time: 10:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W608, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Nadeem Khan, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W608, Rockville, Maryland 20850, 240-276-5856, 
<a href="/cdn-cgi/l/email-protection#fd939c99989890d396959c93bd939495d39a928b"><span class="__cf_email__" data-cfemail="aec0cfcacbcbc380c5c6cfc0eec0c7c680c9c1d8">[email&#160;protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Stimulating Access to Research in Residency (R38).
    Date: July 12, 2023.
    Time: 11:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W110, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Priya Srinivasan, Ph.D., Scientific Review 
Officer, Resource and Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W110, Rockville, Maryland 20850, 240-276-5619, 
<a href="/cdn-cgi/l/email-protection#5e2e2c37273f702d2c373037283f2d3f301e30373670393128"><span class="__cf_email__" data-cfemail="98e8eaf1e1f9b6ebeaf1f6f1eef9ebf9f6d8f6f1f0b6fff7ee">[email&#160;protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-10: NCI Clinical and Translational Cancer Research.
    Date: July 26, 2023.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W254, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Susan Lynn Spence, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W254, Rockville, Maryland 20850, 240-620-0819, 
<a href="/cdn-cgi/l/email-protection#5d2e282e3c33732e2d38333e381d333435733a322b"><span class="__cf_email__" data-cfemail="4d3e383e2c23633e3d28232e280d232425632a223b">[email&#160;protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: May 3, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-09776 Filed 5-8-23; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
View on FederalRegister.gov →Plain-text source
Indexed from Federal Register on May 9, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.